ERAS Stock: Price, Earnings History and SEC Filings
Erasca, Inc. (ERAS) last traded at $14.35, down 4.21% on the latest session and down 2.1% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $-0.14 against an analyst estimate of $-0.12, a miss of 16.7%.
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
ERAS earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | Aug 11, 2026 | $-0.14 | $-0.12 | -16.67% |
| Mar 2026 | May 11, 2026 | $-0.11 | $-0.19 | +42.11% |
| Dec 2025 | Mar 12, 2026 | $-0.10 | $-0.11 | +9.09% |
| Sep 2025 | Nov 12, 2025 | $-0.11 | $-0.11 | +0.00% |
ERAS beat the analyst EPS estimate in 2 of its last 4 reported quarters. Source: Nasdaq.
How ERAS reacts to earnings
Across its last 8 earnings releases, ERAS moved 3.4% on average the next session, in either direction. It rose after 4 of 8 reports.
| Report date | Released | Next-session move |
|---|---|---|
| 2026-08-11 | After close | +1.47% |
| 2026-05-11 | After close | -0.57% |
| 2026-03-12 | After close | -7.03% |
| 2026-01-20 | After close | +2.45% |
| 2025-11-12 | After close | -4.15% |
| 2025-08-12 | After close | +3.85% |
| 2025-05-13 | After close | -4.51% |
| 2025-03-20 | After close | +3.38% |
Based on the dates of earnings-release 8-K filings (SEC EDGAR) and daily closing prices (Yahoo Finance). Past reactions do not predict future ones.
ERAS financial history
| Fiscal year | Revenue | Net income | Free cash flow | Net margin | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | – | -$125M | -$96M | – | $-0.44 |
| 2024 | – | -$162M | -$109M | – | $-0.69 |
| 2023 | – | -$125M | -$103M | – | $-0.83 |
| 2022 | – | -$243M | -$118M | – | $-1.99 |
| 2021 | – | -$123M | -$91M | – | $-1.85 |
| 2020 | – | -$102M | -$34M | – | – |
Source: annual figures from 10-K filings on SEC EDGAR. The year shown is the calendar year the fiscal year ended. Free cash flow is operating cash flow minus capital spending.
Latest SEC filings for ERAS
- 8-K · Oct 16, 2026Officer or director change
- 8-K · Aug 24, 2026Other events
- 10-Q · Aug 11, 2026
- 8-K · Aug 11, 2026Results of operations, Financial statements and exhibits
- 8-K · Aug 10, 2026Officer or director change
- 8-K · Jul 14, 2026Other events, Financial statements and exhibits
- 424B5 · Jul 14, 2026
- 424B5 · Jul 13, 2026
- 8-K · Jul 13, 2026Other events
- 8-K · Jul 1, 2026Shareholder vote
Insider filing activity
ERAS insiders filed 1 Form 4 report in the last 90 days. A Form 4 is how directors and executives disclose purchases, sales and grants of company stock. See the individual filings on SEC EDGAR. Many Form 4 filings are routine, such as scheduled sales or option exercises, so check each filing before drawing a conclusion.
Source: SEC EDGAR.
ERAS news
- Erasca (ERAS), What Is Driving Attention Around The Stock Today?Oct 27, 2026 · finance.yahoo.com
- Erasca (ERAS) Stock Looks Above Fair Value After Its 5x RunOct 19, 2026 · finance.yahoo.com
About Erasca, Inc.
Erasca, Inc. (ERAS) is a US-listed public company on Nasdaq. The SEC classifies its business as Pharmaceutical Preparations. It is incorporated in DE. Its fiscal year ends in December.